Simultaneoususeofagentsthataffecthemostasis,suchasthrombolyticagents,acetylsalicylicacid,nonsteroidalanti-inflammatoryagents,vitaminKantagonists,anddextran,mayenhancetheanticoagulanteffectofheparinsod
Thelikelihoodofharmfuleffectstothefetusinpregnantwomenisextremelysmall.However,becausethepossibilityofharmfuleffectscannotbecompletelyruledout,itisnotrecommendedforpregnantwomenunlessnecessary.Thereis
Thisproductiscarefullyusedinpatientswiththrombocytopeniaandplateletdeficiency,severeliverandkidneydysfunction,uncontrolledhypertension,hypertensiveordiabeticretinopathy.Recentsurgicalpatientsshouldals
Hypersensitivitytodheparinsodiumorotherlowmolecularweightheparinand/orheparin,e.g.aclearhistoryorsuspicionofheparin-inducedimmune-mediatedthrombocytopenia.Acutegastroduodenalulcerandcerebralhemorrhage